The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,717,147 in first-year total cost, median $433,537.
Most frequent study sections
- Special Emphasis Panel[ZRG1 OTC-M (08)]5
- Developmental Therapeutics Study Section[DT]1
- Imaging Guided Interventions and Surgery Study Section[IGIS]1
- Mechanisms of Cancer Therapeutics - 1 Study Section[MCT1]1
Most frequent institutions
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE2
- COLUMBIA UNIV NEW YORK MORNINGSIDE1
- HUGO W. MOSER RES INST KENNEDY KRIEGER1
- MASSACHUSETTS GENERAL HOSPITAL1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers1R01CA272732-01 | MANUEL, EDWIN | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $402,600 | MCT1 |
| 2022 | Multimodal MRI for guiding bacterial cancer therapy1R01CA261974-01A1 | BAI, RENYUANLIU, GUANSHU | HUGO W. MOSER RES INST KENNEDY KRIEGER, MD | $381,690 | IGIS |
| 2022 | Microbial- based targeting of major extracellular matrix components for improved therapy of pancreatic cancer1R01CA266472-01A1 | MANUEL, EDWIN | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $365,200 | DT |
| 2021 | Mechanism of microbiota-mediated potentiation of checkpoint blockade efficacy in lung cancer1R01CA255635-01A1 | LITTMAN, DAN | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $572,168 | ZRG1 |
| 2021 | Immunity to commensal papillomaviruses for cancer therapy1R01CA251755-01A1 | DEMEHRI, SHADMEHRJOH, JOONGHO | MASSACHUSETTS GENERAL HOSPITAL, MA | $562,821 | ZRG1 |
| 2021 | Mechanistic studies of gut microbiota-mediated immune activation against hepatocellular cancer1R01CA250536-01A1 | LI, GUANGFUSTAVELEY-O'CARROLL, KEVIN FINNBAR | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $464,474 | ZRG1 |
| 2021 | Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.1R01CA255670-01 | MCGAHA, TRACY L | UNIVERSITY HEALTH NETWORK, ON | $376,878 | ZRG1 |
| 2020 | Modulation of the tumor microenvironment with probiotic therapies1R01CA249160-01 | DANINO, TAL | COLUMBIA UNIV NEW YORK MORNINGSIDE, NY | $591,316 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.